Singapore, Dec. 17 -- Australian startup Ferronova has raised a further$6 millionto progress the commercialisation of a novel nanoparticle image-guided surgery solution seeking to improve identification of cancer cells and reduce the risk of undetected recurrence following surgery.

Ferronova's super-paramagnetic iron oxide nanoparticles bind to cells found in lymph nodes which aim to enable identification of tissue that could contain cancerous cells. The technology aims to support more informed surgical decision-making and address the problem that cancer cells are often not identified by current imaging and rogue cells may remain undetected in surgery.

Ferronova's latest$6 millionround was led by existing investors Uniseed/UniSuper, Sou...